DEAL TALK: Baring PE: Riding the Pharma Opportunity

Dickenson Intellinetics Private Ltd, January 2009, Pages: 1

The Indian pharmaceutical industry is surfacing as an opportunity warehouse. Companies such as, Sphaera Pharma are at the forefront, garnering the benefits of this renewed investor interest in the sector. In this story, IVCJ Research unveils the perspective of Mr. Akhil Avasthi, Partner - Pharmaceuticals and Healthcare Practice, Baring Private Equity Partners India, on this investment and on the Indian pharmaceutical sector.

Analysis of the deal between Baring Private Equity and Sphaera Pharma.

Baring Private Equity

Sphaera Pharma

New York Life Investment Management Jacob Ballas Fund

Customers who bought this item also bought

• IVCJ's Private Equity Journal for India
• Deal Talk: India AXIS PE: Riding the Infrastructure Opportunity
• Smart Card Industry in India: SIM, Identity, Banking, Transport, Healthcare, Pay TV, Loyalty & PDS
• Business and Investment Opportunity in the Indian Health Insurance Industry: Analyses and Forecasts to 2016
• Indian Insurance & Financial Services - Edition Q2'2012
• Private Equity and Venture Capital Investment Trends in India
• The Indian Prepaid Card Market
• Indian Smart Card Market Report & Forecast: 2011-2016
• Private Wealth Management India - Family Offices for Ultra-High Net worth Individual (UHNWI)
• Indian Health Insurance Market